ASC-话题@MedSci

#ASC#

1352篇内容 | 3922人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939057, encodeId=587b193905e85, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：MEK162（贝美替尼）联合伊马替尼治疗晚期胃肠道间质瘤II期临床研究, objectType=article, longId=194645, objectId=1e85194645d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e85194645d2, replyNumber=0, likeNumber=67, createdTime=2020-12-27, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e85194645d2, moduleTitle=ASCO 2020：MEK162（贝美替尼）联合伊马替尼治疗晚期胃肠道间质瘤II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e85194645d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939063, encodeId=0f4b1939063e1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：奥拉帕利用于BRCA-1/2突变铂敏感复发性卵巢癌患者的疗效及安全性分析（SOLO2研究）, objectType=article, longId=194712, objectId=cf45194e12da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf45194e12da, replyNumber=0, likeNumber=108, createdTime=2020-11-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf45194e12da, moduleTitle=ASCO 2020：奥拉帕利用于BRCA-1/2突变铂敏感复发性卵巢癌患者的疗效及安全性分析（SOLO2研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf45194e12da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939056, encodeId=f0a019390562a, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020 ASCO前瞻 | 中美乳腺癌专家面对面专场直播预告, objectType=article, longId=194606, objectId=342919460642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=342919460642, replyNumber=0, likeNumber=73, createdTime=2021-01-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=342919460642, moduleTitle=2020 ASCO前瞻 | 中美乳腺癌专家面对面专场直播预告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=342919460642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939015, encodeId=9f9e193901511, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：经股动脉经导管主动脉瓣置换术血管和出血并发症的发生率、时间趋势以及相关结局, objectType=article, longId=186373, objectId=b4f31863e3d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f31863e3d5, replyNumber=0, likeNumber=55, createdTime=2020-09-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f31863e3d5, moduleTitle=Circ：Cardiovasc Inte：经股动脉经导管主动脉瓣置换术血管和出血并发症的发生率、时间趋势以及相关结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f31863e3d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939075, encodeId=4cde19390e5e9, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=OCC 2020丨彭道泉：强化降脂在超高危ASCVD患者中聚焦斑块逆转价值和新趋势, objectType=article, longId=195003, objectId=760919500377, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=760919500377, replyNumber=0, likeNumber=103, createdTime=2021-03-04, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=760919500377, moduleTitle=OCC 2020丨彭道泉：强化降脂在超高危ASCVD患者中聚焦斑块逆转价值和新趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=760919500377)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939101, encodeId=d768193910170, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Nutr Metab Cardiovasc Dis：摄入富含大豆的饮食或能通过调节肠道微生物组来影响机体血压, objectType=article, longId=199052, objectId=51b5199052a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51b5199052a7, replyNumber=0, likeNumber=76, createdTime=2020-08-17, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51b5199052a7, moduleTitle=Nutr Metab Cardiovasc Dis：摄入富含大豆的饮食或能通过调节肠道微生物组来影响机体血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51b5199052a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939100, encodeId=802419391004f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=VASCEPA（二十碳五烯酸乙酯）有助于减少呼吸道病毒感染, objectType=article, longId=199053, objectId=ca9d19905394, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9d19905394, replyNumber=0, likeNumber=69, createdTime=2021-01-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9d19905394, moduleTitle=VASCEPA（二十碳五烯酸乙酯）有助于减少呼吸道病毒感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca9d19905394)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939092, encodeId=038219390924c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗, objectType=article, longId=196596, objectId=cd881965961c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd881965961c, replyNumber=0, likeNumber=163, createdTime=2020-07-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd881965961c, moduleTitle=Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd881965961c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939013, encodeId=10ae1939013bd, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Clin Oncol：局部前列腺癌的分子生物标记：ASCO指南, objectType=article, longId=185761, objectId=bb22185e613a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb22185e613a, replyNumber=0, likeNumber=80, createdTime=2020-12-05, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb22185e613a, moduleTitle=J Clin Oncol：局部前列腺癌的分子生物标记：ASCO指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb22185e613a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939058, encodeId=03e51939058a0, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：泰瑞沙在早中期NSCLC中的疗效将公布, objectType=article, longId=194646, objectId=99c1194646de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99c1194646de, replyNumber=0, likeNumber=67, createdTime=2021-03-05, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99c1194646de, moduleTitle=ASCO 2020：泰瑞沙在早中期NSCLC中的疗效将公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99c1194646de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939033, encodeId=bc0c193903391, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Braz J Cardiovasc Surg：轻度术前肾功能不全患者冠状动脉搭桥术后的结果, objectType=article, longId=189152, objectId=cc1d189152fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d189152fb, replyNumber=0, likeNumber=72, createdTime=2020-10-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d189152fb, moduleTitle=Braz J Cardiovasc Surg：轻度术前肾功能不全患者冠状动脉搭桥术后的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d189152fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939014, encodeId=011e1939014b8, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：Harmony流出道早期可行性研究的3年结果, objectType=article, longId=186124, objectId=b72b18612415, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b72b18612415, replyNumber=0, likeNumber=90, createdTime=2020-07-01, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b72b18612415, moduleTitle=Circ：Cardiovasc Inte：Harmony流出道早期可行性研究的3年结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b72b18612415)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939066, encodeId=70c019390660b, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：新辅助治疗是否改善可切除胰腺癌患者预后？, objectType=article, longId=195015, objectId=16171950156b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16171950156b, replyNumber=0, likeNumber=148, createdTime=2020-06-02, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16171950156b, moduleTitle=ASCO 2020：新辅助治疗是否改善可切除胰腺癌患者预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16171950156b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939097, encodeId=1a60193909e83, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Circ：Cardiovasc Inte：球囊与自扩张瓣膜治疗二叶式主动脉瓣狭窄的比较, objectType=article, longId=198144, objectId=0b421981449a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b421981449a, replyNumber=0, likeNumber=50, createdTime=2021-03-05, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b421981449a, moduleTitle=Circ：Cardiovasc Inte：球囊与自扩张瓣膜治疗二叶式主动脉瓣狭窄的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b421981449a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939005, encodeId=3842193900579, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2019 ASCRS临床实践指南：阑尾肿瘤的管理, objectType=article, longId=183532, objectId=f215183532df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f215183532df, replyNumber=0, likeNumber=0, createdTime=2020-03-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f215183532df, moduleTitle=2019 ASCRS临床实践指南：阑尾肿瘤的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f215183532df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939030, encodeId=e3351939030ae, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2020年ASCO-SITC：真实世界中淋巴瘤免疫疗法的不良事件发生率高于临床试验, objectType=article, longId=187875, objectId=07d418e875f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07d418e875f9, replyNumber=0, likeNumber=75, createdTime=2020-09-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07d418e875f9, moduleTitle=2020年ASCO-SITC：真实世界中淋巴瘤免疫疗法的不良事件发生率高于临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07d418e875f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939089, encodeId=f7f2193908979, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％, objectType=article, longId=196200, objectId=2de719620026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de719620026, replyNumber=0, likeNumber=64, createdTime=2020-10-17, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de719620026, moduleTitle=非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de719620026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939070, encodeId=870119390e0f8, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威, objectType=article, longId=195028, objectId=3b871950281b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b871950281b, replyNumber=0, likeNumber=85, createdTime=2020-12-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b871950281b, moduleTitle=ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b871950281b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939004, encodeId=856319390044f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Arterioscler Thromb Vasc Biol：MTHFR基因和血清叶酸相互作用降低血清同型半胱氨酸, objectType=article, longId=183287, objectId=870118328ef6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=870118328ef6, replyNumber=0, likeNumber=76, createdTime=2019-12-07, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=870118328ef6, moduleTitle=Arterioscler Thromb Vasc Biol：MTHFR基因和血清叶酸相互作用降低血清同型半胱氨酸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=870118328ef6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939103, encodeId=b26119391036c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Res :中国房颤患病率居世界前列！PURE研究新分析, objectType=article, longId=199446, objectId=bc5319944638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc5319944638, replyNumber=0, likeNumber=70, createdTime=2021-03-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc5319944638, moduleTitle=Cardiovasc Res :中国房颤患病率居世界前列！PURE研究新分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc5319944638)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：MEK162（贝美替尼）联合伊马替尼治疗晚期胃肠道间质瘤II期临床研究

2020-12-27

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：奥拉帕利用于BRCA-1/2突变铂敏感复发性卵巢癌患者的疗效及安全性分析（SOLO2研究）

2020-11-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020 ASCO前瞻 | 中美乳腺癌专家面对面专场直播预告

2021-01-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：经股动脉经导管主动脉瓣置换术血管和出血并发症的发生率、时间趋势以及相关结局

2020-09-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

OCC 2020丨彭道泉：强化降脂在超高危ASCVD患者中聚焦斑块逆转价值和新趋势

2021-03-04

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Nutr Metab Cardiovasc Dis：摄入富含大豆的饮食或能通过调节肠道微生物组来影响机体血压

2020-08-17

quxin068 (审核中...)

前往app查看评论内容

#ASC#

VASCEPA（二十碳五烯酸乙酯）有助于减少呼吸道病毒感染

2021-01-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：TAVI后的冠脉通路和经皮冠脉介入治疗

2020-07-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Clin Oncol：局部前列腺癌的分子生物标记：ASCO指南

2020-12-05

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：泰瑞沙在早中期NSCLC中的疗效将公布

2021-03-05

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Braz J Cardiovasc Surg：轻度术前肾功能不全患者冠状动脉搭桥术后的结果

2020-10-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：Harmony流出道早期可行性研究的3年结果

2020-07-01

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：新辅助治疗是否改善可切除胰腺癌患者预后？

2020-06-02

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Circ：Cardiovasc Inte：球囊与自扩张瓣膜治疗二叶式主动脉瓣狭窄的比较

2021-03-05

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2019 ASCRS临床实践指南：阑尾肿瘤的管理

2020-03-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2020年ASCO-SITC：真实世界中淋巴瘤免疫疗法的不良事件发生率高于临床试验

2020-09-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％

2020-10-17

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2020：K药联合仑伐替尼的“可乐组合”在肾透明细胞癌再显威

2020-12-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Arterioscler Thromb Vasc Biol：MTHFR基因和血清叶酸相互作用降低血清同型半胱氨酸

2019-12-07

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Res :中国房颤患病率居世界前列！PURE研究新分析

2021-03-06

科室
- - 订阅+
  - 更多科室
工具
服务